| Post | Subject | | |
#1041
|
PFE/Upjohn merges with MYL, forming new US-based company:
|
DewDiligence
| 07/29/19 09:24:47 AM |
|
#1052
|
More than doubled my position in this .."last
|
OMOLIVES
| 10/11/19 01:51:11 PM |
|
#1051
|
AKCA/IONS ink ANGPTL3 license with PFE—$250M up-front:
|
DewDiligence
| 10/07/19 08:19:38 AM |
|
#1048
|
PFE’s ESMO lineup:
|
DewDiligence
| 09/19/19 09:39:46 AM |
|
#1047
|
$PFE Pfizer shares remain attractively valued, says Cowen
|
stockguard
| 09/04/19 03:19:24 PM |
|
#1046
|
PFE, GSK launch global OTC-healthcare company: #msg-150264555.
|
DewDiligence
| 08/01/19 10:44:36 AM |
|
#1045
|
Transcript of MYL-PFE/Upjohn CC:
|
DewDiligence
| 07/30/19 05:38:22 PM |
|
#1044
|
PFE 2Q19 CC transcript:
|
DewDiligence
| 07/30/19 08:21:28 AM |
|
#1043
|
Tax addendum—The PFE/Upjohn-MYL merger is fully taxable for
|
DewDiligence
| 07/29/19 09:39:58 AM |
|
#1042
|
PFE 2Q19 financials…
|
DewDiligence
| 07/29/19 09:25:20 AM |
|
#1041
|
PFE/Upjohn merges with MYL, forming new US-based company:
|
DewDiligence
| 07/29/19 09:24:47 AM |
|
#1040
|
PFE,MYL near deal merging MYL with PFE’s off-patent
|
DewDiligence
| 07/27/19 12:57:02 PM |
|
#1039
|
Lyrica goes generic in US:
|
DewDiligence
| 07/22/19 04:44:03 PM |
|
#1038
|
Small molecules targeting.
|
IPO$
| 06/22/19 10:12:05 AM |
|
#1037
|
PFE acquires ARRY for $11.4B in cash…
|
DewDiligence
| 06/17/19 10:50:10 AM |
|
#1036
|
FDA approves Bavencio/Inlyta combination in first-line RCC:
|
DewDiligence
| 05/15/19 10:59:02 AM |
|
#1035
|
Drug price fixing, list of defendants,
|
JLS
| 05/14/19 07:37:24 PM |
|
#1034
|
FDA approves PFE’s tafamidis for ATTR—US list price
|
DewDiligence
| 05/06/19 08:02:24 AM |
|
#1033
|
Viagra has been available as a US generic
|
DewDiligence
| 05/02/19 06:42:45 PM |
|
#1032
|
Started writing cash covered puts two weeks ago
|
GreedyAgorist
| 05/02/19 06:18:34 PM |
|
#1031
|
What will most likely happen to the Viagra
|
BioSwing
| 05/02/19 05:35:15 PM |
|
#1030
|
PFE 1Q19 CC transcript:
|
DewDiligence
| 05/01/19 09:44:34 AM |
|
#1029
|
Shorts have their eyes on Pfizer.
|
TopMarketGainers
| 04/30/19 07:36:34 PM |
|
#1028
|
PFE 1Q19 CC slides:
|
DewDiligence
| 04/30/19 10:04:40 AM |
|
#1027
|
PFE 1Q19 results and (very slight) 2019 guidance raise:
|
DewDiligence
| 04/30/19 09:04:44 AM |
|
#1026
|
PFE getting hammered this week thinking about starting
|
leftovers
| 04/17/19 11:21:04 AM |
|
#1024
|
Pfe to buy atos?
|
xfrozenx
| 03/28/19 02:17:37 PM |
|
#1023
|
PFE inks GT-drug-development deal with (private) Vivet Therapeutics—lead
|
DewDiligence
| 03/20/19 08:00:08 AM |
|
#1022
|
Pfizer Inc $PFE Has A Cold, Watch This
|
ITMS
| 03/12/19 12:36:00 PM |
|
#1021
|
PFE sold $5B of 3-30-year bonds two days ago:
|
DewDiligence
| 03/06/19 05:22:19 PM |
|
#1020
|
PFE reveals 7 new serotypes in Prevnar-20 pneumonia vaccine:
|
DewDiligence
| 02/28/19 09:57:16 AM |
|
#1017
|
PFE 4Q18 CC transcript:
|
DewDiligence
| 01/30/19 09:09:31 AM |
|
#1016
|
PFE 4Q18 results:
|
DewDiligence
| 01/29/19 01:15:06 PM |
|
#1015
|
Another Leading Pharma Stock Coming Into Major Chart
|
ITMS
| 01/28/19 12:08:08 PM |
|
#1014
|
I have been an AMRN investor for 4
|
Markipeach
| 01/11/19 01:41:05 PM |
|
#1013
|
Heard some rumors that you guys are looking
|
massulo52
| 01/10/19 04:16:20 PM |
|
#1012
|
PFE, GSK form consumer-health JV: #msg-145552190.
|
DewDiligence
| 12/19/18 08:32:23 AM |
|
#1011
|
PFE boosts dividend and authorizes new $10B buyback:
|
DewDiligence
| 12/14/18 06:30:14 PM |
|
#1010
|
PFE starts phase-3 for Prevnar-20—the successor to Prevar-13
|
DewDiligence
| 12/14/18 09:22:31 AM |
|
#1009
|
ABBV settles Humira-biosimilar litigation with PFE: #msg-145185001.
|
DewDiligence
| 11/30/18 10:38:53 AM |
|
#1008
|
Caverstem looks to be a much better option
|
Poseidon360
| 11/13/18 01:18:43 PM |
|
#1007
|
Will guys with ED stick to the blue
|
JVegas
| 11/12/18 12:20:34 AM |
|
#1006
|
Transcript of PFE 3Q18 CC:
|
DewDiligence
| 10/31/18 09:51:29 AM |
|
#1005
|
PFE 3Q18 results:
|
DewDiligence
| 10/30/18 09:38:35 AM |
|
#1004
|
PFE-NVS clinical-trial collaboration in NASH: #msg-144519047.
|
DewDiligence
| 10/29/18 10:14:39 AM |
|
#1003
|
Wrong board?
|
DewDiligence
| 10/01/18 09:14:08 AM |
|
#1002
|
CEO, Ian Read retiring Dec 31—to be succeeded
|
DewDiligence
| 10/01/18 09:13:16 AM |
|
#1001
|
WOOOW they’re finally releasing news on their investigation
|
RetroSpect
| 10/01/18 01:00:51 AM |
|
#1000
|
FDA approves PFE’s Vizimpro (dacomitinib) for NSCLC with
|
DewDiligence
| 09/27/18 07:44:41 PM |
|
#998
|
Pfizer gets mentioned in Abuse deterrent article.
|
NASDAQ2020
| 09/17/18 07:44:13 AM |
|
#997
|
Bavencio/Inlyta shows statsig-better PFS than Sutent monotherapy in
|
DewDiligence
| 09/11/18 01:09:01 PM |
| Post | Subject | | |